Comparison of PD-L1 Immunohistochemical Staining between EBUS-TBNA and Resected Non-Small Cell Lung Cancer Specimens

被引：0
|
作者：
Sakata, K. [1 ]
Midthun, D. [1 ]
Mullon, J. [2 ]
Kern, R. [2 ]
Nelson, D. [2 ]
Edell, E. [1 ]
Jett, J. [3 ]
Aubry, M. C. [4 ]
机构：
[1] Mayo Clin, Pulm & Crit Care Med, Rochester, MN USA
[2] Mayo Clin, Rochester, MN USA
[3] Natl Jewish Hlth, Denver, CO USA
[4] Mayo Clin, Lab Med & Pathol, Rochester, MN USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
Non-small cell lung cancer; PD-L1; immunotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.07-016
引用
收藏
页码：S2000 / S2001
页数：2
相关论文
共 50 条
  • [31] Comparative Study Between Adenocarcinoma And Squamous Cell Carcinoma In Advanced Non-Small Cell Lung Cancer Diagnosed By Ebus-Tbna
    Lee, Y. -M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [32] Comparison of 22C3 PD-L1 Expression between Surgically Resected Specimens and Paired Tissue Microarrays in Non-Small Cell Lung Cancer
    Li, Chao
    Huang, Cheng
    Mok, Tony S.
    Zhuang, Wu
    Xu, Haipeng
    Miao, Qian
    Fan, Xirong
    Zhu, Weifeng
    Huang, Yunjian
    Lin, Xiandong
    Jiang, Kan
    Hu, Dan
    Chen, Xiaohui
    Huang, Peisha
    Lin, Gen
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (10) : 1536 - 1543
  • [33] PD-L1 Expression is not a Predictive Factor for Recurrence in Resected Non-small Cell Lung Cancer
    Nozomu Motono
    Takaki Mizoguchi
    Masahito Ishikawa
    Shun Iwai
    Yoshihito Iijima
    Hidetaka Uramoto
    Lung, 2023, 201 : 95 - 101
  • [34] PD-L1 Expression is not a Predictive Factor for Recurrence in Resected Non-small Cell Lung Cancer
    Motono, Nozomu
    Mizoguchi, Takaki
    Ishikawa, Masahito
    Iwai, Shun
    Iijima, Yoshihito
    Uramoto, Hidetaka
    LUNG, 2023, 201 (01) : 95 - 101
  • [35] Comparison of PD-L1 expression between paired cytologic and histologic specimens from non-small cell lung cancer patients
    C. Kuempers
    L. I. S. van der Linde
    M. Reischl
    W. Vogel
    F. Stellmacher
    M. Reck
    D. Heigener
    K. F. Rabe
    J. Kirfel
    S. Perner
    L. Welker
    Virchows Archiv, 2020, 476 : 261 - 271
  • [36] Comparison of PD-L1 expression between paired cytologic and histologic specimens from non-small cell lung cancer patients
    Kuempers, C.
    van der Linde, L. I. S.
    Reischl, M.
    Vogel, W.
    Stellmacher, F.
    Reck, M.
    Heigener, D.
    Rabe, K. F.
    Kirfel, J.
    Perner, S.
    Welker, L.
    VIRCHOWS ARCHIV, 2020, 476 (02) : 261 - 271
  • [37] PD-L1 Testing in Cytological Non-Small Cell Lung Cancer Specimens: A Comparison with Biopsies and Review of the Literature
    Mansour, Mohammed S. I.
    Lindquist, Kajsa Ericson
    Seidal, Tomas
    Mager, Ulrich
    Mohlin, Rikard
    Tran, Lena
    Hejny, Kim
    Holmgren, Benjamin
    Violidaki, Despoina
    Dobra, Katalin
    Dejmek, Annika
    Planck, Maria
    Brunnstrom, Hans
    ACTA CYTOLOGICA, 2021, 65 (06) : 501 - 509
  • [38] Prospective evaluation of EBUS-TBNA specimens for programmed death-ligand 1 expression in non-small cell lung cancer patients: a pilot study
    Guarize, Juliana
    Rocco, Elena Guerini
    de Marinis, Filippo
    Sedda, Giulia
    Bertolaccini, Luca
    Donghi, Stefano Maria
    Casiraghi, Monica
    Di Tonno, Clementina
    Barberis, Massimo
    Spaggiari, Lorenzo
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2021, 47 (04)
  • [39] Important Benefits of EBUS-TBNA in Assessing PD-L1 Expression in NSCLC
    Centanaro, Gianna Vargas
    Forcen, Elena
    Morales, Beatriz
    Alvarez-Sala, J. L.
    Calle, Myriam
    Bernabe, M. Jose
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [40] Non-Small Cell Lung Cancer, PD-L1, and the Pathologist
    Kerr, Keith M.
    Nicolson, Marianne C.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2016, 140 (03) : 249 - 254
12345